Opportunity Information: Apply for RFA CA 19 030
The NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required), announced by the Department of Health and Human Services through the National Institutes of Health (NIH) and specifically the National Cancer Institute (NCI), is a discretionary grant opportunity designed to help exceptional postdoctoral researchers move quickly from mentored training into fully independent faculty careers. The central aim is to build and sustain a strong pipeline of newly independent, NCI-supported investigators by giving promising postdocs a structured, funded path that starts in a mentored environment and then transitions into independent research support once they secure a tenure-track or equivalent position. In practical terms, the program targets postdoctoral fellows who already have substantial doctoral-level preparation (research and/or clinical doctoral degrees) and who are ready for independence without needing many additional years of supervised training.
This opportunity uses the K99/R00 mechanism, which is built around two connected phases. The first phase (K99) supports a mentored postdoctoral period intended to round out skills, publications, and career development milestones needed to compete successfully for an independent academic role. The second phase (R00) provides independent NCI research support after the awardee transitions into a tenure-track or equivalent faculty position, helping them establish their own research program and generate the early results typically needed for long-term competitiveness (for example, positioning for subsequent major NIH research grants). The overarching purpose is to reduce the gap that often exists between the end of postdoctoral training and the point at which a researcher can reliably secure stable independent funding, while also encouraging a timely move into independence.
A defining feature of this specific announcement is the label "Independent Clinical Trial Required." That wording signals that the proposed research is expected to involve an independent clinical trial component under the applicant's direction as part of the planned work. Applicants considering basic, translational, clinical, or population-oriented projects should pay close attention to that requirement, since it affects study design, feasibility, regulatory planning, and the level of clinical trial leadership expected of the candidate during the award. In addition, NCI explicitly encourages applications from researchers working in data science and cancer control science, highlighting these as priority scientific areas where the institute is seeking to strengthen the next generation of independent investigators.
The funding opportunity is identified as RFA-CA-19-030 and falls under the Health and Education activity categories, with CFDA number 93.398. The applicant eligibility is broad at the institutional level and includes many types of U.S.-based organizations that can host NIH-funded research and training activities, such as public and private institutions of higher education, nonprofit organizations (including those with and without 501(c)(3) status), for-profit organizations (other than small businesses), small businesses, and various government entities (state, county, city/township, special districts), as well as eligible Native American tribal governments and organizations and public housing authorities/Indian housing authorities. While institutions apply and administer the award, the program is fundamentally aimed at supporting individual early stage postdoctoral researchers, so the fit between the candidate, the mentoring environment, and the plan to transition into an independent faculty role is central to the intent of the mechanism.
The opportunity was created on December 20, 2018, with an original closing date of February 26, 2019, and NCI anticipated making about 16 awards under this announcement. The award ceiling is listed as 0 in the provided source data, which typically indicates that a specific maximum dollar cap is not stated in that field of the record rather than implying unlimited funding; actual budget limits and allowable costs are ordinarily defined by NIH policy and the details in the full funding announcement. Overall, the program can be understood as a career-launch award: it is structured to identify standout early postdoctoral scientists, support their final mentored preparation, and then provide an on-ramp to independence with dedicated NCI research funding once they attain a faculty-equivalent position, with particular encouragement for applicants advancing cancer-related data science and cancer control research.Apply for RFA CA 19 030
- The Department of Health and Human Services, National Institutes of Health in the education, health sector is offering a public funding opportunity titled "NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.398.
- This funding opportunity was created on Dec 20, 2018.
- Applicants must submit their applications by Feb 26, 2019. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 16 candidate(s).
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For profit organizations other than small businesses, Small businesses, Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00)?
This is a discretionary grant opportunity from the Department of Health and Human Services through the National Institutes of Health (NIH), specifically the National Cancer Institute (NCI). It is designed to help exceptional early stage postdoctoral researchers move quickly from mentored postdoctoral training into fully independent faculty careers, with structured funding that supports both stages of that transition.
What is the main purpose of this funding opportunity?
The central purpose is to build and sustain a strong pipeline of newly independent, NCI-supported investigators. The award is meant to reduce the gap between the end of postdoctoral training and the point at which a researcher can reliably secure stable independent funding, while encouraging a timely move into independence.
Who is this award intended to support?
The program is fundamentally aimed at supporting individual early stage postdoctoral researchers who already have substantial doctoral-level preparation (research and/or clinical doctoral degrees) and who are considered ready to move toward independence without needing many additional years of supervised training.
What does the K99/R00 mechanism mean?
The K99/R00 mechanism is made up of two connected phases. The first phase (K99) supports a mentored postdoctoral period focused on career development and preparing the candidate to compete for an independent academic position. The second phase (R00) provides independent NCI research support after the awardee transitions into a tenure-track or equivalent faculty position.
What is the K99 phase designed to do?
The K99 phase supports a mentored postdoctoral period intended to help the researcher finalize skills, publications, and career development milestones needed to successfully compete for an independent faculty role.
What is the R00 phase designed to do?
The R00 phase provides independent NCI research support once the awardee secures a tenure-track or equivalent faculty position. The intent is to help the researcher establish an independent research program and generate early results that strengthen long-term competitiveness for future major NIH research grants.
When does the award transition from K99 to R00?
The award transitions after the awardee moves into a tenure-track or equivalent faculty position, at which point the independent R00 research support begins.
What does "Independent Clinical Trial Required" mean in this announcement?
This label indicates that the proposed research is expected to include an independent clinical trial component under the applicant's direction as part of the planned work. This affects study design, feasibility considerations, regulatory planning, and the level of clinical trial leadership expected of the candidate during the award.
Does this opportunity apply only to clinical research?
The announcement notes that applicants considering basic, translational, clinical, or population-oriented projects should pay close attention to the independent clinical trial requirement, since the proposed work is expected to involve an independent clinical trial component.
Are there priority scientific areas highlighted by NCI for this award?
Yes. NCI explicitly encourages applications from researchers working in data science and cancer control science, identifying these as priority areas where NCI is seeking to strengthen the next generation of independent investigators.
What is the funding opportunity number for this announcement?
The funding opportunity is identified as RFA-CA-19-030.
What is the CFDA number listed for this opportunity?
The CFDA number provided is 93.398.
What activity categories does this opportunity fall under?
This opportunity falls under the Health and Education activity categories.
What types of organizations are eligible to apply at the institutional level?
Eligibility at the institutional level is broad and includes many U.S.-based organizations capable of hosting NIH-funded research and training activities. Examples listed include public and private institutions of higher education; nonprofit organizations (with or without 501(c)(3) status); for-profit organizations (other than small businesses); small businesses; and government entities such as state, county, city/township, and special districts. The list also includes eligible Native American tribal governments and organizations, and public housing authorities/Indian housing authorities.
If institutions apply, who is the award really for?
While institutions apply and administer the award, the program is intended to support individual early stage postdoctoral researchers. The fit between the candidate, the mentoring environment, and the plan to transition into an independent faculty role is central to the purpose of the mechanism.
How many awards did NCI anticipate making under this announcement?
NCI anticipated making about 16 awards under this announcement.
When was this opportunity created and what was the original closing date?
The opportunity was created on December 20, 2018, with an original closing date of February 26, 2019.
Is there a stated maximum award amount (award ceiling) in the provided information?
The award ceiling is listed as 0 in the provided source data. In context, that typically means a specific maximum dollar cap is not stated in that particular field of the record, rather than indicating unlimited funding. Actual budget limits and allowable costs are ordinarily defined by NIH policy and the details in the full funding announcement.
What kind of career stage does this award target?
It targets outstanding early stage postdoctoral researchers who are prepared to move relatively quickly from mentored training into independence, rather than spending many additional years in supervised postdoctoral training.
How should applicants think about the mentoring environment in relation to this award?
Because the award is explicitly designed to support a mentored-to-independent transition, the mentoring environment and the candidate's plan to reach independence (including securing a tenure-track or equivalent position) are described as central to the intent of the mechanism.
Browse more opportunities from the same category: Education, Health
Next opportunity: Coastal Program - Great Lakes Restoration Initiative
Previous opportunity: CDC's Collaboration with Academia to Strengthen Public Health Workforce Capacity
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA CA 19 030
Applicants also applied for:
Applicants who have applied for this opportunity (RFA CA 19 030) also looked into and applied for these:
| Funding Opportunity |
|---|
| Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed) Apply for RFA CA 19 022 Funding Number: RFA CA 19 022 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed) Apply for RFA CA 19 021 Funding Number: RFA CA 19 021 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed) Apply for RFA CA 19 020 Funding Number: RFA CA 19 020 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed) Apply for RFA CA 19 019 Funding Number: RFA CA 19 019 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) Apply for RFA CA 19 027 Funding Number: RFA CA 19 027 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
| Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional) Apply for RFA CA 19 025 Funding Number: RFA CA 19 025 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
| Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional) Apply for RFA CA 19 026 Funding Number: RFA CA 19 026 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
| Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) Apply for RFA CA 19 023 Funding Number: RFA CA 19 023 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
| Revisions for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) Apply for RFA CA 19 024 Funding Number: RFA CA 19 024 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
| Distance Learning and Telemedicine Grants. Apply for RUS 19 02 DLT Funding Number: RUS 19 02 DLT Agency: Department of Agriculture, Utilities Programs Category: Education, Health Funding Amount: $500,000 |
| Distance Learning and Telemedicine Grants--Opioid. Apply for RUS 19 01 DLT Funding Number: RUS 19 01 DLT Agency: Department of Agriculture, Utilities Programs Category: Education, Health Funding Amount: $500,000 |
| Feasibility and Planning Studies for Development of Specialized Programs of Research Excellence (SPOREs) to Investigate Cancer Health Disparities (P20 Clinical Trial Optional) Apply for RFA CA 19 034 Funding Number: RFA CA 19 034 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $800,000 |
| Optimizing the Management and Outcomes for Cancer Survivors Transitioning to Follow-up Care (R01 Clinical Trial Required) Apply for RFA CA 19 035 Funding Number: RFA CA 19 035 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| American Schools and Hospitals Abroad Program Worldwide Apply for 72ASHA19RFA00001 Funding Number: 72ASHA19RFA00001 Agency: Agency for International Development Category: Education, Health Funding Amount: $2,000,000 |
| Revision Applications to Support the Application of Informatics Technology for Cancer Research (R01 Clinical Trials Optional) Apply for RFA CA 19 062 Funding Number: RFA CA 19 062 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $100,000 |
| Revision Applications to Support the Application of Informatics Technology for Cancer Research (U01 Clinical Trials Optional) Apply for RFA CA 19 061 Funding Number: RFA CA 19 061 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $100,000 |
| Revision Applications to Support the Application of Informatics Technology for Cancer Research (U24 Clinical Trials Optional) Apply for RFA CA 19 063 Funding Number: RFA CA 19 063 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $100,000 |
| The National Drug Abuse Treatment Clinical Trials Network (UG1 Clinical Trial Required) Apply for RFA DA 20 024 Funding Number: RFA DA 20 024 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Limited Competition: Pediatric Brain Tumor Consortium (UM1 Clinical Trials Required) Apply for RFA CA 19 059 Funding Number: RFA CA 19 059 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $3,300,000 |
| Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Coordination, Analysis, and Scientific Outreach (UM1 Clinical Trial Not Allowed) Apply for RFA DA 20 027 Funding Number: RFA DA 20 027 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 19 030", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.